Sabina Janciauskiene
71 – 80 of 88
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
Human mast cells decrease SLPI levels in type II - like alveolar cell model, in vitro.
(
- Contribution to journal › Article
- 2002
-
Mark
Interactions of A beta with endogenous anti-inflammatory agents: a basis for chronic neuroinflammation in Alzheimer's disease.
(
- Contribution to journal › Scientific review
-
Mark
Modulation of inflammatory mediators and ppargammaand nfkappab expression by pravastatin in response to lipoproteins in human monocytes in vitro.
(
- Contribution to journal › Article
-
Mark
Atorvastatin activates PPAR-gamma and attenuates the inflammatory response in human monocytes.
(
- Contribution to journal › Article
-
Mark
Detection of circulating and endothelial cell polymers of Z and wild type alpha 1-antitrypsin by a monoclonal antibody.
(
- Contribution to journal › Article
-
Mark
Suppression of cholesterol 7 alpha-hydroxylase transcription and bile acid synthesis by an alpha(1)-antitrypsin peptide via interaction with alpha(1)-fetoprotein transcription factor
(
- Contribution to journal › Article
-
Mark
Alpha1-antichymotrypsin/Alzheimer's peptide Abeta(1-42) complex perturbs lipid metabolism and activates transcription factors PPARgamma and NFkappaB in human neuroblastoma (Kelly) cells.
(
- Contribution to journal › Article
-
Mark
Effects of native and cleaved forms of alpha1-antitrypsin on ME 1477 tumor cell functional activity.
(
- Contribution to journal › Article
-
Mark
Glioma cell activation by Alzheimer's peptide Abeta1-42, alpha1-antichymotrypsin, and their mixture.
(
- Contribution to journal › Article
-
Mark
Atorvastatin activates PPAR-γ and attenuates the inflammatory response in human monocytes
(
- Contribution to journal › Article